Age-Related Macular Degeneration (ARMD) Completed Phase 4 Trials for Bevacizumab (DB00112)

Also known as: Age-related macular degeneration / Macular Degeneration / Senile macular degeneration / Macular degeneration senile / Macular degeneration (senile) of retina, unspecified

IndicationStatusPhase
DBCOND0034150 (Age-Related Macular Degeneration (ARMD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03552770Single or Combined Protocols for NV-AMDHealth Services Research
NCT00805649Combined Therapy in Age-Related Macular Degeneration (ARMD)Treatment